• 

  Canadian Malnutrition Awareness Week, our annual campaign, aims to enhance learning of clinicians, healthcare providers and consumers around malnutrition. CMAW 2024 dates to follow.

  Learn more
• 

  Learn more
• 

  In primary care, 1 dollar spent on nutrition interventions can save up to 99 dollars by reducing medication use, hospitalizations and freeing up physician time.

  Learn more
• 

  Nutrition risk screening is the first step in identifying patients at risk for malnutrition.

  Learn more
• 

  Up to 1 in 3 hospitalized children are malnourished upon admission to hospital and at risk of further deterioration.

  Learn more
• 

  Learn More
• 

  Check out the CPS module Reducing the burden of paediatric malnutrition: Practical tools to guide

  Learn more

Cannabis Edibles, Efficacy, and Special Populations

October 14, 2020

-

2020-10-14 2020-10-14 Cannabis Edibles, Efficacy, and Special Populations

A PHP Error was encountered

Severity: Warning

Message: Undefined property: stdClass::$location

Filename: events/view.php

Line Number: 19

Backtrace:

File: /home/cnsscn/apps/cmtf_2023/application/views/events/view.php
Line: 19
Function: _error_handler

File: /home/cnsscn/apps/cmtf_2023/application/third_party/MX/Loader.php
Line: 362
Function: include

File: /home/cnsscn/apps/cmtf_2023/application/third_party/MX/Loader.php
Line: 304
Function: _ci_load

File: /home/cnsscn/apps/cmtf_2023/application/controllers/Events.php
Line: 39
Function: view

File: /home/cnsscn/apps/cmtf_2023/index.php
Line: 347
Function: require_once

America/New_York

 

Date: Wednesday, October 14, 2020

Time: 12:00 -1:00 pm ET

Speaker: Dr. Michael Beazely

To register, CLICK HERE

Cannabis edibles have now been on the regulated Canadian recreational cannabis market for about a year. We will learn about cannabis edibles and other dosage forms. We will also discuss the current best evidence for the use of medical cannabis to treat disease. Special populations will also be discussed, including youth, older adults, patients with renal or liver dysfunction, and pregnancy and lactation.

Learning objectives:

After this talk, learners will be able to:

1. Compare contrast recreational, medical, and pharmaceutical cannabis dosage forms.
2. Demonstrate knowledge about the current state of evidence for the efficacy of cannabinoids to treat disease
3. Employ prevention and harm reduction approaches to mitigate harms associated with cannabis use in youth, older adults, and in pregnancy

---

About the Speakers

Dr. Michael Beazely is a faculty member at the School of Pharmacy, University of Waterloo. His research lab research focuses on understanding how growth factor receptors and G protein-coupled receptors modulate ion channels and neuronal cell function. Prof. Beazely’s clinical research includes the evaluation of undergraduate pharmacy education with respect to substance use and ongoing educational tool development for practicing health professionals. He is interested in assessing interventions by community pharmacists aimed at reducing harms associated with substance use and understanding the intersection between drug use and ongoing pharmaceutical care.

To register, CLICK HERE

---